Skip to main content
. 2021 Feb 18;66(8):761–768. doi: 10.1038/s10038-020-00896-5

Table 2.

Genetic characteristics of 20 HLDs patients

Pt Gene Transcript CDS Protein Or N/R GE CA SI Po MT Co MC PR
1 TUBB4A NM_006087.3 c.1164 G > T p.(M388I) d N 3.4 23.8 D D D D N D
2 TUBB4A NM_006087.3 c.1062 C > G p.(C354W) d R 0.6 25.5 D D D D D D
3 TUBB4A NM_006087.3 c.1062 C > G p.(C354W) d R 0.6 25.5 D D D D D D
4 POLR3A NM_007055.3 c.661_662insCCT p.(P220_L221insS) m N 5.1
c.1770 + 5 G > C p.(P591Vfs*28) p N 4.8 7.2 -–
5 POLR1C NM_001318876.1 c.322 C > T p.(H108Y) p N 5.6 29.8 D D D D D D
c.883_885delAAG p.(K295del) m R 4.9 14.6
6 POLR1C NM_001318876.1 c.326 G > A p.(R109H) p R 4.8 34.0 D D D D D D
c.901 C > T p.(R301W) m N 4.9 35.0 D D D D D D
7 SOX10 NM_006941.3 c.227 T > A p.(V76D) d N 4.4 27.6 D D D D D D
8 TMEM106B NM_001134232.1 c.754 G > A p.(D252N) d # 5.4 32.0 D D D D D D
9 DEGS1 NM_001321541.1 c.110 T > C p.(M37T) p # 5.5 24.6 D D D D D D
c.770 G > A p.(W257*) m # 5.9 43.0 D
10 TMEM63A NM_014698.2 c.1385 T > A p.(I462N) d # 5.1 31.0 D D D D D D
11 TMEM63A NM_014698.2 c.503 G > A p.(G168E) d # 5.9 26.9 D D D D D D

Pt patient, Or origin, m maternal, p paternal, d de novo, N novel, R reported, GE GERP + + RS, CA CADD, SI SIFT, Po PolyPhen, MT mutation taster, Co Condel, MC M-CAP, PR PROVEAN, D probably damaging in polyphen or deleterious in other software, N neutral, # patients with these variants have been reported in our previous paper